Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Biological variation of insulin resistance, testosterone and cardiovascular risk factors in women with polycystic ovarian syndrome: modification with rimonabant [20 mg/day] compared to metformin [1500 mg/day].

Next Previous
X
Search
Trial Profile

Biological variation of insulin resistance, testosterone and cardiovascular risk factors in women with polycystic ovarian syndrome: modification with rimonabant [20 mg/day] compared to metformin [1500 mg/day].

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 06 Sep 2021

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Rimonabant (Primary) ; Metformin
  • Indications Metabolic syndrome; Obesity; Polycystic ovary syndrome
  • Focus Pharmacodynamics

    • Most Recent Events

    • 06 Jun 2008 Status changed to completed based on the presentation of primary endpoint data at the 68th Annual Scientific Sessions of the American Diabetes Association.
    • 06 Jun 2008 Results presented at the 68th Annual Scientific Sessions of the American Diabetes Association.
    • 09 Mar 2007 New trial record.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top